Perceived and objective understandings of AKI and related risks may be low among patients who had AKI during hospitalization, ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president ...